Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

BACKGROUND: Patients with malignancy are particularly vulnerable to infection with Severe Acute Respiratory Disease‐Coronavirus‐2 (SARS‐CoV‐2) given their immunodeficiency secondary to their underlying disease and cancer‐directed therapy. We report a case series of patients with cancer who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Douglas, Seah, Carina, Schneider, Thomas, Bhalla, Sheena, Feld, Jonathan, Naymagon, Leonard, Wang, Bo, Patel, Vaibhav, Jun, Tomi, Jandl, Thomas, Rahman, Farah, Liu, Sean T. H., Aberg, Judith A., Bouvier, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537286/
https://www.ncbi.nlm.nih.gov/pubmed/32945149
http://dx.doi.org/10.1002/cam4.3457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537286/
https://www.ncbi.nlm.nih.gov/pubmed/32945149
http://dx.doi.org/10.1002/cam4.3457

Ejemplares similares